ALB and neoplasm: Albumin nanoparticles offer enhanced receptor-mediated uptake through albumin-binding proteins, biocompatibility, natural biodegradability without toxic degradation products, intrinsic tumor-targeting properties, ease of modification and most importantly, established clinical precedent with nab-paclitaxel [63,64,65].